BlackRock Advisors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$10.4M Sell
130,055
-1,377,329
-91% -$109M 0.01% 854
2016
Q3
$120M Sell
1,507,384
-365,546
-20% -$29.5M 0.12% 185
2016
Q2
$146M Sell
1,872,930
-1,054,954
-36% -$75.2M 0.15% 159
2016
Q1
$161M Buy
2,927,884
+604,963
+26% +$33M 0.17% 137
2015
Q4
$143M Buy
2,322,921
+15,602
+0.7% +$984K 0.15% 150
2015
Q3
$146M Buy
2,307,319
+711,729
+45% +$50.8M 0.16% 153
2015
Q2
$117M Buy
1,595,590
+341,464
+27% +$24.7M 0.12% 183
2015
Q1
$82M Buy
1,254,126
+490,307
+64% +$32.6M 0.08% 237
2014
Q4
$49.7M Buy
763,819
+4,247
+0.6% +$274K 0.05% 341
2014
Q3
$45.7M Sell
759,572
-602,775
-44% -$39.4M 0.05% 367
2014
Q2
$94.3M Sell
1,362,347
-789,655
-37% -$51.2M 0.09% 239
2014
Q1
$141M Sell
2,152,002
-648,881
-23% -$42.2M 0.14% 175
2013
Q4
$174M Buy
2,800,883
+992,318
+55% +$57.5M 0.17% 155
2013
Q3
$97M Sell
1,808,565
-6,725
-0.4% -$346K 0.1% 222
2013
Q2
$82.8M Buy
+1,815,290
New +$78.7M 0.09% 236

Other funds holding STJ

BlackRock Advisors's STJ Position: Q4 2016 in Review

BlackRock Advisors reduced its St Jude Medical (STJ) stake by 91% in Q4 2016, selling an estimated $109M and leaving 130,055 shares worth $10.4M. The position accounts for 0.01% of the portfolio, ranked #854.

BlackRock Advisors first reported a position in STJ in Q2 2013 and has held it in 15 quarters since. The position peaked at $174M in Q4 2013. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • BlackRock Advisors held 130,055 shares of St Jude Medical worth $10.4M as of Q4 2016.
  • BlackRock Advisors sold 1,377,329 St Jude Medical shares in Q4 2016, an estimated $109M.
  • St Jude Medical made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #854 holding.
  • BlackRock Advisors first reported a position in St Jude Medical in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's St Jude Medical position peaked at $174M in Q4 2013.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.